Histomorphological Features and Ezrin Expression in Testicular Seminomas in Dogs: An Association with Potential Prognostic Value

87% of canine testicular seminomas expressed ezrin; higher expression correlated with the more invasive diffuse subtype (n=23)

Journal: Journal of Comparative Pathology | Published: 2026-03-31 | Type: Journal Article | PMID: 41921423 Authors: Pereira de Souza SC et al. (Universidade Federal Fluminense, Brazil) Funding/COI: Funding not listed; no conflicts of interest declared

Summary

A Brazilian veterinary team examined 23 canine testicular seminomas for two histological markers: PAS staining (used to classify tumor subtype) and ezrin immunoexpression (a cytoskeletal protein linked to invasiveness in several human cancers). PAS staining cleanly separated the intratubular from the diffuse subtype, mirroring how human seminomas are classified. Ezrin was detected in 87% of samples and correlated with the diffuse subtype — the histologically more locally invasive form. No clinical outcome data were collected.

Claims

• 20 of 23 (87%) canine seminomas showed cytoplasmic ezrin immunolabelling
• Intratubular seminomas were PAS-positive; diffuse seminomas were PAS-negative
• A high percentage of ezrin-positive cells was found in 18 of 23 cases
• High ezrin expression correlated positively with the diffuse seminoma pattern
• Diffuse canine seminomas displayed local invasive histological features associated with ezrin labelling
• Authors propose ezrin as a biological marker of local invasiveness potential in canine seminomas

Study Quality

This is a retrospective immunohistochemical case series — 23 samples, no follow-up, no survival data, no clinical outcome tracking. The word "prognostic" in the title is doing work the data cannot support. The study establishes a histomorphological correlation between ezrin expression and tumor subtype; it does not establish prognosis. That distinction matters. The methodology itself — PAS staining plus anti-ezrin immunohistochemistry — is standard veterinary pathology practice, applied competently. Specific p-values and correlation coefficients are not reported in the abstract, so effect sizes cannot be evaluated without the full text.

Red Flags

• n=23 is underpowered for any biomarker validation claim
• No metastasis rates, survival curves, or recurrence data — "prognostic value" in the title is not supported by the data presented
• Dog study; translation to human testicular seminoma requires independent human cohort data, which does not exist yet
• Funding source not disclosed
• No comparison to established prognostic markers in canine seminoma
• The title promises prognostic value; the abstract delivers a correlation

Strengths

• PAS staining results contribute to standardizing canine seminoma classification, where no consensus currently exists
• Ezrin is biologically plausible: it links the plasma membrane to the actin cytoskeleton and is overexpressed in invasive human cancers including gastric, colorectal, and osteosarcoma
• Fills a genuine gap — ezrin is barely studied in human testicular tumors and unstudied in dogs
• No declared conflicts of interest

Verdict

A small pilot study that makes one defensible observation: diffuse canine seminomas express more ezrin than intratubular ones, and diffuse seminomas look more locally invasive under the microscope. That is a reasonable hypothesis-generating finding. It is not a validated prognostic biomarker. The title oversells it. For researchers in comparative oncology or veterinary pathology there is a useful data point here; for anyone hoping to apply this to human seminoma management, there is nothing yet. File under: interesting lead, n too small to act on.